Søgning
Søgning på udtrykket 'pneumocystis jirovecii' giver 19 resultater
Nyt fra tidsskrifterne [18] Aktuelle smitsomme sygdomme [1]
Nyt fra tidsskrifterne [18]
BMC Infectious Diseases
11.04.2025
. Background. Children with Langerhans cell histiocytosis (LCH) are particularly susceptible to infections such as Pneumocystis jirovecii pneumonia (PJP) due to the immunosuppressive effects of chemotherapy, which can progress to acute respiratory distress syndrome (ARDS) and respiratory failure…
American Journal of Respiratory and Critical Care Medicine
1.03.2025
American Journal of Respiratory and Critical Care Medicine, Volume 211, Issue 3, Page 509-512, March 2025.
BMC Infectious Diseases
5.02.2025
. Abstract. . Introduction. Cunninghamella elegans infections cause rare and severe mucormycosis. Bordetella bronchiseptica and Pneumocystis jirovecii relate to pneumonia. They are all clinically uncommon pathogens and no reports of co-infections have been reported. . . . Case presentation…
Clinical Microbiology and Infection
27.12.2024
Pneumocystis jirovecii pneumonia (PCP) is a serious opportunistic infection in people living with HIV (PWH) who have low CD4 counts. Despite its side effects, trimethoprim-sulfamethoxazole (TMP-SMX) is currently considered the primary treatment for PCP.
Clinical Microbiology and Infection
11.11.2024
The diagnosis of Pneumocystis jirovecii pneumonia (PCP) can be challenging because of diagnostic tests that are imperfect and/or invasive. The Fungitell serum (1→3)-β-D-glucan (BDG) assay is a non-invasive blood test studied for PCP; however, the manufacturer-recommended cut-off of 80pg/mL is not well validated for this disease.Objectives: We conducted a systematic review and meta-analysis to determine the diagnostic test accuracy of the Fungitell BDG assay for the diagnosis of PCP.
Infection
16.10.2024
. Abstract. A 43-year-old male patient presented to the emergency department with progressive dyspnea. CT scan showed pronounced cystic lesions and ground glass opacitiy in both lungs and diagnosis of HIV infection was established. Bronchoscopy confirmed diagnosis of pneumocystis jirovecii pneumonia (PCP). The radiological presentation with perihilar large cysts is typical for PCP in HIV-infected patients, but rarely encountered today. .
BMC Infectious Diseases
13.10.2024
. Abstract. . Background. Pneumocystis jirovecii pneumonia (PcP) is an opportunistic infection associated with immunocompromised patients. The development of novel immunotherapies has promoted the incidence of PcP. This study describes the clinical course and outcome of PcP in chimeric antigen receptor (CAR) T cell recipients with hematological malignancies. . . …
BMC Infectious Diseases
1.10.2024
…. . Introduction. Nephrotic syndrome (NS) is a common chronic kidney disease that is often accompanied by a state of immunodeficiency. Immunosuppression increases the risk of infections, with Pneumocystis jirovecii and Nocardia brasiliensis being two opportunistic pathogens that can cause severe infections in patients with compromised immune function…
BMC Infectious Diseases
26.09.2024
. Abstract. . Background. Serum (1,3)-β-D-glucan (BDG) detection for diagnosis of Pneumocystis jirovecii pneumonia (PJP) in non-human immunodeficiency virus (HIV) immunocompromised patients lacks intensive care unit (ICU)-specific data. We aimed to assess its performance and determine the optimal cutoff for PJP in ICU population. . . . Methods…
BMC Infectious Diseases
29.08.2024
…ications. SLE patients still have a higher mortality rate than the general population. Infectious disease is reported as one of the major causes of death in patients with SLE. Although bacteria are the most often isolated pathogens from patients with SLE, Pneumocystis jirovecii pneumonia (PJP) is more deadly than bacterial infection. . . . Methods…
BMC Infectious Diseases
16.04.2025
. Background. Pneumocystis jirovecii pneumonia (PCP) in non-human immunodeficiency virus (HIV) patients is associated with high morbidity and mortality. Although prior studies have linked delayed treatment to worse outcomes, they are often limited by small sample sizes and inadequate adjustment for confounders. Therefore, we evaluated whether early treatment after hospital admission improves mortality in non-HIV PCP, adjusting for patient characteristics. …
BMC Infectious Diseases
26.02.2025
. Abstract. . Background. Opportunistic infections (OIs) in patients with advanced HIV disease remain a serious health issue, particularly in low-and middle-income countries. . . . Objectives…
Clinical Infectious Diseases
14.12.2024
…atients, which included mainly voriconazole (44.37%) and posaconazole (31.71%). The cumulative incidence of IFD (proven and probable) at 1 year after allo-HSCT was 6.3%. Pathogens were identified in 47.97% of IFD cases and mainly included Candida spp. (17.89%), Mucorales (13.01%), Aspergillus spp. (8.94%), and Pneumocystis jirovecii (6.5%). Multivariate analysis identified the following factors associated with IFD: disease at advanced stage (hazard ratio [HR]= 2.55; 95% confidence interval [CI]: 1.58-4.12 P
BMC Infectious Diseases
3.11.2024
… . Background. A recent database study and meta-analysis reported that adjunctive glucocorticoid therapy reduces mortality in patients with non-human immunodeficiency virus-associated (non-HIV) Pneumocystis jirovecii pneumonia (PCP), having hypoxemia. However, the optimal glucocorticoid dose remains unclear…
BMC Infectious Diseases
30.10.2024
. Abstract. . Background. Information on the comparison of blood microbiota between human immunodeficiency virus (HIV)-infected and HIV-uninfected patients with suspected sepsis by metagenomic next-generation sequencing (mNGS) is limited. . . . Methods…
BMC Infectious Diseases
27.10.2024
. Abstract. . Background. Pneumocystis jirovecii pneumonia (PJP) is an opportunistic infection that primarily affects immunocompromised individuals. Typical symptoms of PJP include the subacute onset of dyspnea, nonproductive cough, and low-grade fever. In hematology patients, particularly those who are allogeneic stem cell transplant recipients, the disease often presents with a more aggressive clinical course…
Clinical Infectious Diseases
20.08.2024
…BAL) has been established, the role of follow-up testing remains unclear.Methods . This was a retrospective single-center study. The yield of follow-up PCR for Aspergillus species, Mucorales agents, Fusarium species, Scedosporium species, dimorphic fungi, Pneumocystis jirovecii, and Candida species on plasma and/or BAL was measured at intervals of 1, 2, 3, and 4 weeks following a negative result.Results …
BMC Infectious Diseases
4.06.2024
…nd risk factors of KTRs with the COVID-19 virus variant Omicron. . . . Results. We included thirty patients in our study, with sixteen exhibiting single infection of COVID-19 and fourteen experiencing co-infections, predominantly with Pneumocystis jirovecii. Notably, patients with severe cases demonstrated significantly elevated levels of C-reactive protein (CRP) and interleukin-6 compared to those with moderate cases (P
Aktuelle smitsomme sygdomme [1]
Aktuelle smitsomme sygdomme [1]
Medscape Infectious Diseases
10.04.2025
Stopping prophylactic treatment in patients with rheumatic disease on > 12.5 mg/d of prednisone-equivalent corticosteroids raises the risk for Pneumocystis jirovecii pneumonia. . Medscape Medical News